↓ Skip to main content

Post-vaccination myositis and myocarditis in a previously healthy male

Overview of attention for article published in Allergy, Asthma & Clinical Immunology, February 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#46 of 831)
  • High Attention Score compared to outputs of the same age (94th percentile)

Mentioned by

news
1 news outlet
twitter
36 tweeters
facebook
5 Facebook pages

Citations

dimensions_citation
36 Dimensions

Readers on

mendeley
45 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Post-vaccination myositis and myocarditis in a previously healthy male
Published in
Allergy, Asthma & Clinical Immunology, February 2016
DOI 10.1186/s13223-016-0114-4
Pubmed ID
Authors

Matthew P. Cheng, Michael G. Kozoriz, Amir A. Ahmadi, John Kelsall, Katryn Paquette, Jake M. Onrot

Abstract

The immunological literature has been redefining clinical phenomena as hypotheses emerge regarding causal links between triggers, immunologic manifestations, and their specific inflammatory cascades. Of late, autoimmune manifestations that appear to be caused by an external adjuvant have been grouped into a complex syndrome referred to as autoimmune/inflammatory syndrome induced by adjuvants (ASIA). This syndrome may present with diverse clinical problems, which may include neurocognitive impairment, inflammatory musculoskeletal changes, and constitutional symptoms. There is evidence in the literature linking vaccines to different auto-immune manifestations. Vaccines have not traditionally been reported to trigger ASIA, although reports are emerging linking the human papilloma virus and hepatitis B vaccines to it. We report the first suspected case of ASIA in a previously healthy patient who received the Fluad seasonal influenza vaccine, which contains the MF59 adjuvant. He presented to hospital with profound weakness and was diagnosed with severe rhabdomyolysis. He also had elevated troponin-I and extensive cardiac investigations enabled the diagnosis of myocarditis. His infectious and rheumatologic work-ups were negative. He responded well to conservative management and did not require immune suppressive therapy. Given the benefits of the influenza vaccine, and the low incidence of clinically significant complications, we encourage ongoing seasonal influenza immunization. However, ongoing surveillance is required to evaluate the occurrence of rare adverse events, including ASIA.

Twitter Demographics

The data shown below were collected from the profiles of 36 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 45 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Singapore 1 2%
Unknown 44 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 20%
Other 5 11%
Student > Bachelor 4 9%
Student > Ph. D. Student 3 7%
Student > Postgraduate 3 7%
Other 9 20%
Unknown 12 27%
Readers by discipline Count As %
Medicine and Dentistry 17 38%
Nursing and Health Professions 4 9%
Agricultural and Biological Sciences 4 9%
Biochemistry, Genetics and Molecular Biology 2 4%
Social Sciences 1 2%
Other 3 7%
Unknown 14 31%

Attention Score in Context

This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 November 2022.
All research outputs
#1,024,183
of 22,460,793 outputs
Outputs from Allergy, Asthma & Clinical Immunology
#46
of 831 outputs
Outputs of similar age
#20,326
of 381,243 outputs
Outputs of similar age from Allergy, Asthma & Clinical Immunology
#1
of 1 outputs
Altmetric has tracked 22,460,793 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 831 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.8. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 381,243 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them